Amarin Gives Double Dose of Bearish News
Irish drug maker Amarin spooked investors yesterday afternoon, when it said it would borrow $100 million to build its own sales force for its Vascepa drug rather than seeking a partner. AMRN drops 18 percent before the bell on my tradeMONSTER platform.
Smith & Wesson Raises Guidance
Gun maker Smith & Wesson reported second-quarter sales of $136.56 million, beating the $134.78 million estimate. Management also boosted full-year earnings and revenue guidance. SWHC is up more than 2 percent in early trading.
Comtech Issues Bleak Forecast
Comtech Telecommunications reported first-quarter sales of $91 million, lagging the $92.64 million consensus estimate. It also sees that top-line number shrinking by 15 percent in the current quarter, while analysts had expected a small increase. In addition, per-share earnings are also seen at less than one-third of Street estimates. CMTL fell 13 percent after the bell yesterday but hasn't traded yet this morning.